Abstract
Immune checkpoint blockade therapy targeting CTLA4 and PD-1/PD-L1 is a promising strategy in the treatment of different types of cancers. However, the......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
